ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 945

Non-Canonical NF-Kappa B Signaling Enhances Angiogenesis In a Novel 3D Spheroid Model Of Rheumatoid Arthritis Synovial Inflammation

Chrissta X. Maracle1, Ae-Ri Noort2, Katinka P.M. van Zoest2 and Sander W. Tas1, 1Department of Clinical Immunology & Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Department of Clinical Immunology & Rheumatology and Laboratory for Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Angiogenesis and signal transduction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Angiogenesis plays a crucial role in rheumatoid arthritis (RA) synovitis and is regarded as a switch from acute to chronic inflammation. Previously, we have demonstrated that NF-kappaB inducing kinase (NIK) mediated non-canonical NF-kappaB signaling contributes to pathological angiogenesis in endothelial cells (EC). However, many of the current in vitro models of angiogenesis focus solely on EC and do not include interactions with other cell types. RA synovial fibroblasts (RASF) are important contributors to angiogenesis in synovial inflammation, and thus a model including both RASF and EC would more accurately represent the pathophysiology of RA angiogenesis.

Objective:

To develop better in vitro models to study the interaction between RASF and EC and to further delineate the role of the non-canonical NF-kappaB pathway in pathological angiogenesis.

Methods:

First, we utilized a 2 dimensional (2D) model to evaluate the effects of non-canonical NF-kappaB signaling on angiogenesis. RASF and human umbilical cord EC (HUVEC) were co-cultured in the presence or absence of lymphotoxin (LT), LIGHT, or growth factors (bFGF/VEGF). EC were visualized through immunohistochemical staining of CD31, which was semi-quantitatively scored. Next, we developed a novel 3 dimensional (3D) model in which HUVEC and RASF were labeled with green or orange cell tracker dye, respectively, and incubated overnight to form spheroids. Subsequently, the spheroids were harvested and plated in a collagen solution, and medium with or without LT, LIGHT or growth factors (bFGF/VEGF) was added. After 48 hours, spheroids were fixed and imaged through confocal microscopy. Cumulative EC sprout length and the number of sprouts was quantified using Leica QWin Plus software.

Results:

The 2D culture model revealed an increase in CD31 positive area under all stimulation conditions, with LIGHT inducing almost a 2-fold increase (p<0.05). Confocal analysis of the 3D model showed that spheroids containing HUVEC and RASF formed sprouts under all conditions and that LT and LIGHT caused significant increases (p<0.05) in cumulative sprout length. Interestingly, the total number of sprouts formed by each spheroid also increased significantly. Preliminary results indicate that siRNA-mediated knock-down of NIK in EC leads to a clear reduction in cumulative sprout length, as well as in total sprout numbers.

Conclusion:

Both the 2D and 3D model demonstrate that activation of the non-canonical NF-kappaB pathway via LT and LIGHT enhances angiogenesis. However, in contrast to the 2D model, the 3D model allows visualization of actual blood vessel formation. Importantly, preliminary results demonstrate that the observed increase in angiogenesis is at least in part NIK-dependent. This suggests that NIK may be a novel therapeutic target to block pathological angiogenesis in RA, thereby halting disease progression. Of interest, it is also possible to incorporate immune cells in the 3D model to study their contributions to pathological angiogenesis in RA synovial inflammation, which makes this a valuable tool for future studies.


Disclosure:

C. X. Maracle,
None;

A. R. Noort,
None;

K. P. M. van Zoest,
None;

S. W. Tas,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-canonical-nf-kappa-b-signaling-enhances-angiogenesis-in-a-novel-3d-spheroid-model-of-rheumatoid-arthritis-synovial-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology